Skip to Main Content

Paper Details

Estimated glomerular filtration rates through 144â¿¿weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine.
HIV Clinical Trials
4
2015
HIV-1, abacavir, atazanavir, lamivudine, ritonavir

Datasets